S&Co Inc Edwards Lifesciences Corp Transaction History

S&Co Inc

$1.53 Billion
Q3 2024

A detailed history of S&Co Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, S&Co Inc holds 61,555 shares of EW stock, worth $4.66 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

61,555

Previous 49,435 24.52%

Holding current value

$4.66 Million

Previous $4.57 Million 11.04%

% of portfolio

0.27%

Previous 0.32%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$59.7 - $93.78 $723,564 - $1.14 Million	12,120 Added 24.52%	61,555 $4.06 Million
Q2 2024 Aug 08, 2024	SELL	$84.3 - $94.31 $8,430 - $9,431	-100 Reduced 0.2%	49,435 $4.57 Million
Q1 2024 May 09, 2024	BUY	$72.54 - $95.56 $580,320 - $764,480	8,000 Added 19.26%	49,535 $4.73 Million
Q4 2023 Feb 12, 2024	BUY	$61.71 - $77.76 $318,115 - $400,852	5,155 Added 14.17%	41,535 $3.17 Million
Q2 2022 Aug 09, 2022	SELL	$86.5 - $128.27 $40,655 - $60,286	-470 Reduced 1.28%	36,380 $3.46 Million
Q1 2022 May 05, 2022	BUY	$101.96 - $128.34 $1.15 Million - $1.44 Million	11,250 Added 43.95%	36,850 $4.34 Million
Q4 2021 Feb 08, 2022	BUY	$106.37 - $130.68 $1.6 Million - $1.96 Million	15,000 Added 141.51%	25,600 $3.32 Million
Q3 2020 Dec 11, 2020	SELL	$67.19 - $87.44 $134,380 - $174,880	-2,000 Reduced 15.87%	10,600 $846,000
Q2 2020 Dec 16, 2020	BUY	$57.54 - $76.95 $483,336 - $646,380	8,400 Added 200.0%	12,600 $871,000
Q4 2019 Jan 24, 2020	SELL	$71.7 - $82.09 $93,210 - $106,717	-1,300 Reduced 23.64%	4,200 $980,000
Q3 2018 Nov 05, 2018	SELL	$45.7 - $58.03 $22,850 - $29,015	-500 Reduced 8.33%	5,500 $958,000
Q3 2017 Nov 02, 2017	BUY	$36.29 - $38.83 $217,740 - $232,980	6,000	6,000 $656,000

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of S&Co Inc, based on Form 13F filings with the SEC.

News

Stay updated on S&Co Inc with notifications on news.

Account